PIP PHOSPHATASE AND INOSITOL PHOSPHOLIPID HOMEOSTATSIS
PIP 磷酸酶和肌醇磷脂稳态
基本信息
- 批准号:5212607
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:3T3 cells Escherichia coli biological signal transduction cell cycle proteins cell differentiation cell growth regulation complementary DNA enzyme activity enzyme mechanism gene expression genetic library growth /development homeostasis immunoprecipitation insulinlike growth factor laboratory rabbit lipid metabolism messenger RNA neoplastic cell culture for noncancer research nucleic acid sequence oligonucleotides phosphatidylinositols polymerase chain reaction protein sequence protein structure function
项目摘要
Many growth factors and hormones elicit their biological response by
stimulating the hydrolysis of phosphatidylinositol 4,5-P2 to produce
diacylglycerol and inositol 1,4,5-P3. Adequate levels of the
polyphosphoinositides used in such signaling appear to be crucial to the
maintenance of proper cell function. Decreases in the levels of
inositol-containing phospholipids have been associated with a variety of
pathological conditions including diabetic neuropathy and Respiratory
Distress Syndrome.
Phosphoinositides are present not only in the plasma membrane but also
occur as part of a distinct nuclear PI cycle. Nuclear PI turnover has
been shown to be regulated by IGF-1 and the levels of nuclear inositol
phospholipids appear to change in cells undergoing differentiation. The
levels of polyphosphoinositides are determined by their relative rates
of synthesis and degradation. While much research has focused on the
synthesis of polyphosphoinositides, comparatively little is known of the
phosphoinositide phosphatases that degrade phosphoinositides. Recent
work has suggested that alterations in these enzymes may be the basis for
changes in nuclear PI homeostasis associated with differentiation.
Furthermore, preliminary data have indicated that activity of several
enzymes involved in PI turnover and cell signaling are modulated in a
cell cycle-dependent fashion suggesting the possibility that inositol
phospholipid homeostasis may be modulated during the cell cycle. Based
on the above considerations, the specific aims of this proposal are:
1. To clone and sequence a PI4-P 4-phosphatase.
2. To define the role of the PI 4-P phosphatase in inositol phospholipid
homeostasis and cell signaling.
3. To examine the expression of PI 4-P 4-phosphatase mRNA and protein
throughout the cell cycle.
4. To elucidate the role of the PI 4-P phosphatase in the nuclear PI
cycle and characterize the effects of IGF's on this cycle.
A PIP phosphatase from rat brain has been purified 76,000-fold in the
laboratory and partially characterized. In the proposed experiments,
protein sequence will be obtained from the purified PIP phosphatase and
used to design probes for the cloning and sequencing of a cDNA
corresponding to this enzyme. The role of the PIP phosphatase in
maintaining inositol phospholipid homeostasis will then be investigated
by overexpressing the PIP phosphatase in 3T3 cells and evaluating its
effect on inositol phosphate and phospholipid levels. The involvement
of the PIP phosphatase in the nuclear PI cycle and the effects of IGF's
on this novel signaling pathway will also be investigated. Insight into
the structure, function and regulation of a PIP phosphatase will aid in
understanding the mechanisms involved in regulating the levels of
phosphoinositides within cells.
许多生长因子和激素引起他们的生物反应,
刺激磷脂酰肌醇4,5-P2的水解以产生
甘油二酯和肌醇1,4,5-P3。 适当水平的
在这种信号传导中使用的多磷酸肌醇似乎是至关重要的,
维持正常的细胞功能。 减少的水平
含有肌醇的磷脂已经与多种
病理状况,包括糖尿病性神经病变和呼吸系统疾病
痛苦综合症。
磷酸肌醇不仅存在于质膜中,
作为一个独特的核PI周期的一部分发生。 核PI营业额
已被证明受IGF-1和核肌醇水平的调节
磷脂似乎在经历分化的细胞中发生变化。 的
多磷酸肌醇的水平由它们的相对速率决定
合成和降解的过程。 虽然许多研究都集中在
对于聚磷酸肌醇的合成,人们知之甚少
降解磷酸肌醇的磷酸肌醇磷酸酶。 最近
研究表明,这些酶的改变可能是
与分化相关的核PI稳态的变化。
此外,初步数据表明,
参与PI周转和细胞信号传导的酶被调节成
细胞周期依赖性方式表明肌醇
细胞周期期间可能会调节磷脂稳态。 基于
基于上述考虑,这项建议的具体目标是:
1.目的:克隆一个PI 4-P4-磷酸酶基因,并进行序列测定.
2.确定PI 4-P磷酸酶在肌醇磷脂中的作用
稳态和细胞信号传导。
3.检测PI 4-P4-磷酸酶mRNA和蛋白的表达
在整个细胞周期中。
4.阐明PI 4-P磷酸酶在核PI中的作用,
周期和特点的影响IGF的对这个周期。
一种来自大鼠脑的PIP磷酸酶已经纯化了76,000倍,
实验室和部分特征。 在拟议的实验中,
蛋白质序列将从纯化的PIP磷酸酶获得,
用于设计用于cDNA克隆和测序的探针
对应于这种酶。 PIP磷酸酶在
维持肌醇磷脂稳态将被研究
通过在3 T3细胞中过表达PIP磷酸酶并评估其
对磷酸肌醇和磷脂水平的影响。 参与
PIP磷酸酶在核PI周期中的作用和IGF的影响
对这种新的信号通路也将进行研究。 洞察
PIP磷酸酶结构、功能和调节将有助于
了解参与调节水平的机制,
细胞内的磷酸肌醇。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA PIKE其他文献
LINDA PIKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
- 批准号:32302245
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
- 批准号:82371775
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
- 批准号:31871817
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
- 批准号:81873549
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
- 批准号:31571933
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
- 批准号:31371861
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
- 批准号:31371845
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
- 批准号:31171774
- 批准年份:2011
- 资助金额:66.0 万元
- 项目类别:面上项目
相似海外基金
Knowledgebase of Escherichia coli Genome and Metabolism
大肠杆菌基因组和代谢知识库
- 批准号:
10716050 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
- 批准号:
10747651 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Inactivation of Escherichia coli using high hydrostatic pressure from viewpoints of cell shrinkage and expansion
从细胞收缩和扩张的角度利用高静水压灭活大肠杆菌
- 批准号:
23K05105 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Metabolic engineering of Escherichia coli for carbon capture and hydrogen storage.
用于碳捕获和氢储存的大肠杆菌代谢工程。
- 批准号:
2869802 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
Development of new removal method targeting Escherichia coli causing colorectal cancer
开发针对引起结直肠癌的大肠杆菌的新去除方法
- 批准号:
23K19489 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Research Activity Start-up
Structural Determinants of Permeation Barriers in Escherichia coli
大肠杆菌渗透屏障的结构决定因素
- 批准号:
10749251 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
- 批准号:
10741541 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A novel genetic switch with an optimal ON/OFF ratio to preserve growth performance prior to Escherichia coli autolysis for enhanced plasmid release
一种具有最佳开/关比的新型基因开关,可在大肠杆菌自溶之前保持生长性能,从而增强质粒释放
- 批准号:
2881246 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR ANTIMICROBIAL RESISTANCE ESCHERICHIA COLI
大肠杆菌耐药性体外诊断的开发
- 批准号:
10912990 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




